Mode
Text Size
Log in / Sign up
N/A N=263 Randomized Quadruple-blind Treatment

Homeopathic Cold Remedy for Children Study

Upper Respiratory Tract Infections

Enrolled (actual)
263
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcome: Primary: Change in Severity of Cold Symptoms — 3.7; 3.7; 3.9; 3.9 units on a scale — p=.86

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Hyland's Cold 'n Cough 4 kids (Drug); placebo (Drug)
Age
Pediatric · 2+ yrs
Sex
All
Sponsor
University of Washington
Primary completion
Aug 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Severity of Cold Symptoms
3.7; 3.7; 3.9; 3.9; 3.8; 3.8 .86
SECONDARY
Change in Non-specific Symptoms
3.6; 3.5; 3.6; 3.6; 3.6; 3.5 .61
SECONDARY
Functional Status
11.0; 10.4; 11.7; 11.8; 12.7; 12.5 .16
SECONDARY
Health Status
4.4; 4.9; 3.8; 4.1; 3.2; 3.4 .10
SECONDARY
Overall Symptom Severity
4.6; 5.5; 4.2; 5.0; 3.7; 4.0 .02 sig

Summary

A randomized controlled trial of a commercially available homeopathic cold remedy will be conducted. A total of 400 children, 2-5 years old, diagnosed with an upper respiratory tract infection will be randomized to receive either the homeopathic remedy or placebo. Parents of study children will administer 5 ml of the study medication up to 6 times per day as needed to treat cold symptoms. One hour after giving a dose the parent will rate change in symptoms (for up to the first 10 doses). In addition, parents will rate their child's overall symptom severity and functional status over the first 3 days of the cold. It is postulated that children receiving the active homeopathic remedy will have better symptom relief and that their symptom severity and functional status will improve more rapidly than those receiving placebo.

Eligibility Criteria

Inclusion Criteria

  • clinical diagnosis of upper respiratory tract infection
  • duration of symptoms < 7 days
  • Parent who speaks English

Exclusion Criteria

  • history of asthma
  • on any prescribed medication
  • prescribed any medication other than acetaminophen or ibuprofen at index visit
  • use of homeopathic remedy within 48 hours of index visit
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01257503). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search